Cite

    Sugawara, S. et al. (2019). Multicenter, placebo‐controlled, double‐blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy‐induced nausea and vomiting in patients receiving highly emetogenic chemotherapy. Cancer. 125 (22), pp. 4076-4083. [Online].